Tumor marker
Template:Distinguish Template:Short description A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers (measure progression or response to therapy). They can be found in bodily fluids or tissue. Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response and monitor therapy.<ref>Template:Cite journal</ref>
Tumor markers can be molecules that are produced in higher amounts by cancer cells than normal cells, but can also be produced by other cells from a reaction with the cancer.<ref name=":0">Template:Citation</ref>
The markers can't be used to give patients a diagnosis but can be compared with the result of other tests like biopsy or imaging.<ref name=":0" />
ClassificationEdit
Tumor markers can be proteins, carbohydrates, receptors and gene products. Proteins include hormones and enzymes. To detect enzyme tumor markers enzyme activity is measured. They were previously widely used, but they have largely been replaced by oncofetal antigens and monoclonal antibodies, due to disadvantages such as most of them lacking organ specificity. Carbohydrates consists of antigens on and/or secreted from tumor cells, these are either high-molecular weight mucins or blood group antigens. Receptors are used to determine prognosis and measure how the patient responds to treatment, while genes or gene product can be analyzed to identify mutations in the genome or altered gene expression.Template:Fact
UsesEdit
Tumor markers may be used for the following purposes:
- Monitoring the malignancy
When a malignant tumor is found by the presence of a tumor marker, the level of marker found in the body can be monitored to determine the state of the tumor and how it responds to treatment. If the quantity stays the same during treatment it can indicate that the treatment isn't working, and an alternative treatment should be considered. Rising levels of tumor marker does not necessarily reflect a growing malignancy but can result from things like unrelated illnesses.
- Reflect the stage of cancer
By determining the stage of cancer, it's possible to give a prognosis and treatment plan.<ref name=":1">Template:Cite journal</ref>
- Screening for cancers
No screening test is wholly specific, and a high level of tumor marker can still be found in benign tumors. The only tumor marker currently used in screening is PSA (prostate-specific antigen).
- Diagnostics
Tumor markers alone can't be used for diagnostic purposes, due to lack of sensitivity and specificity.<ref name=":2">Template:Cite journal</ref> The only approved diagnostic method for cancer is with a biopsy.
- Detects reoccurring cancers
Tumor markers can detect reoccurring cancers in patients post-treatment.<ref name=":1" />
TechniquesEdit
Tumor markers can be determined in serum or rarely in urine or other body fluids, often by immunoassay, but other techniques such as enzyme activity determination are sometimes used. Assaying tumor markers were significantly improved after the creation of ELISA and RIA techniques and the advancement of monoclonal antibodies in the 1960s and 1970s.<ref name=":0" />
For many assays, different assay techniques are available. It is important that the same assay is used, as the results from different assays are generally not comparable. For example, mutations of the p53 gene can be detected through immunohistochemical polymorphism screening of DNA, sequence analysis of DNA, or by single-strand conformational polymorphism screening of DNA. Each assay may give different results of the clinical value of the p53 mutations as a prognostic factor.<ref>Template:Cite journal</ref>
Interlaboratory proficiency testing for tumor marker tests, and for clinical tests more generally, is routine in Europe and an emerging field<ref name="Koepke1992">Template:Cite journal</ref> in the United States. New York state is prominent in advocating such research.<ref>Template:Cite book</ref>
List of commonly used markersEdit
Accuracy and specific useEdit
The ideal tumor marker has the following characteristics:
- Specificity to a certain type of tumor
- Should detect the malignancy earlier than a clinical diagnosis
- Be highly sensitive to avoid false positives
- The level of tumor marker should indicate the state of the malignancy to be able to monitor treatment response.
An ideal tumor marker does not exist, and how they are clinically applied depends on the specific tumor marker. For example, tumor markers like Ki-67 can be used to choose form of treatment or in prognostics but are not useful to give a diagnosis, while other tumor markers have the opposite functionality. Therefore it's important to follow the guidelines of the specific tumor marker.
Tumor markers are mainly used in clinical medicine to support a diagnosis and monitor the state of malignancy or reocurrence of cancer.<ref name=":2" />
See alsoEdit
ReferencesEdit
External linksEdit
Template:Tumor markers Template:Blood tests Template:Authority control